IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 27 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,353 | -49.9% | 99,100 | -19.0% | 0.00% | – |
| Q2 2023 | $362,008 | -16.0% | 122,300 | -21.4% | 0.00% | – |
| Q1 2023 | $430,765 | -74.4% | 155,511 | -51.1% | 0.00% | – |
| Q4 2022 | $1,684,467 | +81.9% | 317,824 | +36.9% | 0.00% | – |
| Q3 2022 | $926,000 | +5.1% | 232,238 | +1.8% | 0.00% | – |
| Q2 2022 | $881,000 | -9.9% | 228,200 | +20.0% | 0.00% | – |
| Q1 2022 | $978,000 | -54.1% | 190,188 | -52.2% | 0.00% | – |
| Q4 2021 | $2,132,000 | +6.5% | 397,570 | +23.6% | 0.00% | – |
| Q3 2021 | $2,001,000 | +1084.0% | 321,705 | +1768.3% | 0.00% | – |
| Q1 2021 | $169,000 | – | 17,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 932,200 | $4,792,000 | 0.21% |
| Ikarian Capital, LLC | 77,650 | $399,000 | 0.05% |
| Gradient Capital Advisors, LLC | 20,000 | $103,000 | 0.04% |
| Belvedere Trading LLC | 37,100 | $209,000 | 0.01% |
| WEST PACES ADVISORS INC. | 1,665 | $8,558 | 0.00% |
| OSAIC HOLDINGS, INC. | 20 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 13,113 | $67,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 57,517 | $295,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,466 | $18,000 | 0.00% |